Delivery Order SPE2DB22D3301-SPE2DB24FY4RW

Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of DESCOVY 200-25 MG TABLET medical products. The contract, valued at $67,063.43, has a firm fixed price and an ultimate completion date of September 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment facilities and other federal healthcare providers nationwide. This award is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET medication. The contract has a firm fixed price of $2,155.42 and a completion date of February 7, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET in 30-count packages. The contract is a firm-fixed price, valued at $14,246.38, with an ultimate completion date of August 5, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, holds several Indefinite Delivery Contracts (IDCs) with various...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $59,422.43, is for the supply of DESCOVY 200-25 MG TABLET medication. The award has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of DESCOVY 200-25 MG TABLET in 30-count packages. The delivery order has a ceiling value of $9,249.35 and a performance period through April 9, 2024. This award is not set aside for any specific business or socioeconomic category. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The order is for the supply of DESCOVY 200-25 MG TABLET (a pharmaceutical product) under a firm fixed price contract with a ceiling value of $8,010.56. The order has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,747.25 firm fixed-price contract is for the delivery of DESCOVY 200-25 MG Tablet, a prescription medication, to support federal healthcare programs. The award has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $11,193.36 and a performance period through March 7, 2024. This award is part of a larger indefinite delivery contract...
The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $20,919.09, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S. The $2,589.45 award has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY4RW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DESCOVY 200-25 MG TABLET in 30-count units. The contract has a firm fixed price of $3,337.23 and a completion date of April 16, 2024. The award is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 7/15/24, 6:54 PM